Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kort

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Neuropharmacology|June 23, 2010
A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in ratsXu-Feng Zhang, Char-Chang Shieh, Mark L Chapman, et al.
Bioorganic & Medicinal Chemistry|June 24, 2010
Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonistsRichard J Perner, John R Koenig, Stanley Didomenico, et al.
Journal of Medicinal Chemistry|June 9, 2006
Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonistsDerek W Nelson, Robert J Gregg, Michael E Kort, et al.
Journal of Medicinal Chemistry|December 13, 2006
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel openerRobert J Altenbach, Michael E Brune, Steven A Buckner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 9, 2008
Molecular determinants of species-specific activation or blockade of TRPA1 channelsJun Chen, Xu-Feng Zhang, Michael E Kort, et al.
Journal of Medicinal Chemistry|March 26, 2016
Substituted Indazoles as Nav1.7 Blockers for the Treatment of PainJennifer M Frost, David A DeGoey, Lei Shi, et al.
Pain|July 13, 2010
A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain modelPamela S Puttfarcken, Ping Han, Shailen K Joshi, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitroWilliam A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.
Neuroscience|May 5, 2007
P2X7-related modulation of pathological nociception in ratsS McGaraughty, K L Chu, M T Namovic, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2019
Inhibition of Interleukin-23-Mediated Inflammation with a Novel Small Molecule Inverse Agonist of ROR<i>γ</i>tStephen B Gauld, Sebastien Jacquet, Donna Gauvin, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Neuropharmacology|June 23, 2010
A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in ratsXu-Feng Zhang, Char-Chang Shieh, Mark L Chapman, et al.
Bioorganic & Medicinal Chemistry|June 24, 2010
Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonistsRichard J Perner, John R Koenig, Stanley Didomenico, et al.
Journal of Medicinal Chemistry|June 9, 2006
Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonistsDerek W Nelson, Robert J Gregg, Michael E Kort, et al.
Journal of Medicinal Chemistry|December 13, 2006
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel openerRobert J Altenbach, Michael E Brune, Steven A Buckner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 9, 2008
Molecular determinants of species-specific activation or blockade of TRPA1 channelsJun Chen, Xu-Feng Zhang, Michael E Kort, et al.
Journal of Medicinal Chemistry|March 26, 2016
Substituted Indazoles as Nav1.7 Blockers for the Treatment of PainJennifer M Frost, David A DeGoey, Lei Shi, et al.
Pain|July 13, 2010
A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain modelPamela S Puttfarcken, Ping Han, Shailen K Joshi, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitroWilliam A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.
Neuroscience|May 5, 2007
P2X7-related modulation of pathological nociception in ratsS McGaraughty, K L Chu, M T Namovic, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2019
Inhibition of Interleukin-23-Mediated Inflammation with a Novel Small Molecule Inverse Agonist of ROR<i>γ</i>tStephen B Gauld, Sebastien Jacquet, Donna Gauvin, et al.
Pageof 6